Objectives: Polyurethanes are widely opted for composing nanofibers due to their ability of spinnability, biocompatibility, high chemical stability, good mechanical and elasticity properties. The desired release behaviours are also achieved by using combination of polyurethanes and various polymers. In the present study, we aimed to investigate effects of polyvinylpyrolidone and ethyl cellulose in polyurethane electrospun nanofibers in terms of the morphological structures and drug release characteristics.
Anahtar kelimeler: Elekro-eğirme yöntemi ile üretilen nanolifler, ilaç salımı, poliüretan, polivinilpirolidon, etil selüloz 1. Introduction: Electrospun nanofibers has attracted a great attention due to their potential applications for biomedical devices, tissue engineering, biosensors, filtration, wound dressing, enzyme immobilization, and drug delivery in recent years. 1 They have received a great attention in drug delivery especially due to their high surface area to volume ratio that could allow drug molecules to diffuse out of matrix readily because of their highly porous structure. 2, 3 In addition, the electrospun nanofibers have other superiorities such as high drug loading capacity, cost-effectiveness, and ease of fabrication process. 4 Polyurethanes (PUs) are widely opted for composing nanofibers due to their ability of spinnability, biocompatibility, chemical stability, good mechanical and elasticity properties. They could generally adapt for many applications such as filters, wound dressing materials, protective textiles, biosensors, biomedical devices, and tissue engineering, owing to their various structures. 5 The addition of the second component such as cellulose derivatives, polyethylene glycol (PEG), polycaprolactone, poly (vinyl alcohol) (PVA), poly (acrylic acid) (PAA) to PUs could give rise to fabrication of a new nanofiber with different morphological and physical structures for special applications. 6, 7 u n c o r r e c t e d p r o o f
The desired release behaviours are also achieved by using various polymer combinations. 8 Ethyl cellulose (EC) is a non-ionic and physiologically inert cellulose derivative. This polymer which is insoluble in the water due to its hydrophobic nature has a relatively small swelling degree. 9 Therefore; it is a suitable compound for preparation of sustained drug release matrix 10 and does not require addition of release modifiers. 11 Polyvinylpyrrolidone (PVP) is a non-ionic, biodegradable and biocompatible polymer made from the monomer N-vinylpyrrolidone. 12, 13 It features an outstanding spinnability in various solvents such as ethanol, methanol, or chloroform. 12, 14 PVP has a hygroscopic property, so that absorbs water up to 40 % of its weight in atmospheric conditions and could result in unstable nanofibers. But besides these properties, PVP is a hydrophilic polymer which leads to fast dissolution and immediate release of drugs. 15 PVP has already been used to modulate release of drugs from the nanofibers. 16 The release behaviour of drug loaded PVP, EC or PVP/EC electrospun nanofibers have been studied by some researchers. [17] [18] [19] [20] However, morphology and drug release characteristics of the electrospun fibers composed of the blends of PU with either EC or PVP have not yet been available in the literature.
In this study, we aimed to investigate effect of EC and PVP in polyurethane electrospun nanofıbers on morphology and drug release characteristics. At the second stage, the fibers were prepared from PU and either hydrophobic polymer EC or hydrophilic polymer PVP blends in different combinations. PU/EC and PU/PVP fibers were evaluated as a drug carrier material to modulate the release profile. The developed PU/EC and PU/PVP fibers in different combination were characterized morphologically and structurally. At the second stage, the effect of EC or PVP content on the release rates of donepezil hydrochloride (DNP), which is a water-soluble drug, are discussed and their kinetic mechanisms were estimated following in vitro release data. 
Materials and Methods

Materials: Polyurethane
Preparation of Electrospun Nanofibers:
Homogeneous PU solutions were prepared by dissolving PU (12.5%, w/v) in dimethylformamide. DNP was added to these clear polymer solutions, and it was dissolved. Following addition of either EC or PVP at different ratio into PU solutions (Table 1) , the mixtures were stirred for an hour to provide a homogenous solution for electrospinning procedure.
The conductivity of these solutions was measured by a conductivity meter (Eutech Instruments, PC2700, Landsmeer, Netherlands) at room temperature. Each of measurements was performed in triplicate.
"INSERT FIGURE 1" "INSERT TABLE 1"
In the electrospinning process ( Fig. 1) , each of the mixed polymer solutions were loaded into 10 mL syringes equipped with the metallic needle of an outer diameter of 0.8x38 mm. A syringe was mounted horizontally on syringe pump (NE-500 Model, New Era Pump Systems, Inc. USA) and aluminium collector. A positive electrode of high voltage power supply (ES 30 Model, Gamma High Voltage Inc., USA) was attached onto a syringe needle. The polymer solution was fixed at rate of 1 mL/h. The high electric voltage was set to 15 kV, the distance between needle tip and aluminium collector distance was 15 cm. All solution preparations and electrospinning were carried out at ambient temperature. 
Morphology of Electrospun
In vitro Drug Release from Electrospun Nanofibers:
In vitro drug release studies were carried out according to method defined in the monograph as "paddle over disk method" of United State Pharmacopeia (USP 38). 21 The nanofiber sections with 2.5 cm diameter were immobilized between a glass container and a sieve of stainless steel. The The cumulative amount of released DNP per cm 2 from electrospun nanofibers was plotted versus time. Each experiment was conducted in triplicate. The UV visible spectrophotometry method was validated for selectivity, linearity, accuracy, and precision. It was determined to be linear over concentration range 2.5-20 μg/mL with a high correlation coefficient (r2>0.999) and accurate, (recovery>98%). There were no interfering absorbances with DNP confirming selectivity of the method.
Analysis of Drug Release Kinetics and Modelling:
In order to understand the mechanism and kinetics of DNP release from electrospun nanofibers, the release data were fitted to kinetic models via free open source software DDSolver ® 22 as described below (1-5):
The zero order kinetic model;
The first order kinetic model; In C= In C 0 +k 1 t
The Higuchi square root kinetic model;
where, C is drug concentration released at time t, C 0 is drug concentration at the beginning, k 0 , k 1 and k 2 are zero, first order and Higuchi release rate constants, respectively.
The Hixson-Crowell kinetic model;
where, W0 is initial amount of drug in the formulation, Wt is remaining amount of drug in the nanofiber at time t and k H is release rate constant for Hixson-Crowell model.
The Korsmeyer-Peppas kinetic model;
Mt/ M∞= KP (5) where, M t is drug concentration released at time t, M ∞ is equilibrium concentration of drug that must be released at infinite time in the release medium, Mt/M∞ is the fraction of drug in the release medium at time t, k KP is release rate constant, n is diffusional exponent indicating type of drug release mechanism. If n equals 1, the release mechanism is zero order; on the other hand, if 0.5 < n < 1, non-Fickian transport is the case. Also, the first 60% drug release data were fitted in this model. 23 The coefficient of correlation (r 2 ) values were determined for the linear curves obtained by regression analysis of drug release profile. The highest r 2 value was selected as the most appropriate model.
Results and Discussion
Preparation of Electrospun Nanofibers:
The solution properties such as type of polymer and its concentration as well as electrospinning process parameters include the flow rate, applied voltage, tip-to-collector distance are crucial to obtain the bead-free electrospun fibers in nanometric scale. 24 Therefore, the preliminary electrospun nanofiber fabrication studies were conducted using pure PU solutions at different concentrations and the electrospinning process parameters such as flow rates, applied voltages, tip-to-collector distance were tested to find the optimum electrospinning process parameters and, polymer concentration as described our previous study. 25 The u n c o r r e c t e d p r o o f results had showed that the bead-free electrospun fibers could be merely obtained with 12.5% (w/v) concentration of PU solution 25 . In the present study, DNP, either EC or PVP at different ratios (Table 1) in the wave number range of 4000-800 cm -1 , spectra of 10/1/1 was not given because there was no differences between 10/1/1 and 10/2/1. Both the spectrum of drug loaded PU/EC and PU/PVP nanofibers have nearly similar characteristic FTIR bands, but the spectra of fibers show some small difference also. Characteristic absorption bands of PU described in detail in our previous study 25 such as: the 1727 cm -1 band, due to the carbonyl groups in urethane bonds (C=O); the 1550 cm -1 band, usually assigned to secondary amide (RCONHR'); the 1630 cm -1 band, assigned to carbonyl groups in urea bond; the 1170 cm -1 band due to C-O stretch and C-N stretch; the 3350 cm -1 and 2944 cm -1 bands from N-H and C-H groups.
Decreasing of characteristic absorption bands of PU at 1727 cm -1 band from 10/2/1 to 10/8/1 (PU/EC/DNP) and also amendments at the 1062 cm -1 and 2952 cm -1 clarifies that EC incorporate to the PU matrix in Fig. 4 . Because of the lower rate of the drug according to PU/EC and PU/PVP mixture, characteristic absorption bands of drug molecule may not be observed. Hence, the interactions could not be determined between the drug and polymers. 26 On the other hand, PVP could also accelerate the release of a water soluble drug, as also reported for poorly water-soluble drug (ibuprofen). 17 Moreover, it is well known that the water-soluble drugs are released fast; this case is a crucial point for the controlled release of these types of drugs. 27 Based on that data, the sustained release behaviour of a water soluble drug from PU/EC electrospun fibers can be possible when the ratio of EC was increased (Fig. 6 ), which would be an advantage for providing a sustained release manner for water-soluble compounds.
"INSERT FIGURE 6"
Analysis of Drug Release Kinetics and Modeling:
The in vitro release data of nanofibers were analyzed using to kinetic models mentioned in the method section to understand the release mechanism and kinetics of model drug from PU/EC electrospun nanofibers. The drug release mechanism and kinetics were determined based on the coefficient of correlation (r 2 ) values, which signifies the goodness of the fit. Table 3 present coefficient of correlation (r 2 ) values estimated for linear curves of PU/EC/DNP electrospun fibers. Also, the coefficient of correlation (r 2 ) values were not been estimated for kinetic models as the drug release from PU/PVP/DNP electrospun fibers were resulted in the immediate release. The regressed results for PU/EC/DNP electrospun fiber at ratio of 10/8/1 exhibited the highest coefficient of correlation (r 2 =0.999) ( Table 3) for Korsmeyer-Peppas model. This result indicated that the release of drug from PU/EC/DNP electrospun fiber in ratio of 10/8/1 was controlled by Fickian diffusion mechanism with a value of the release exponent (n) 0.31 (<0.5). Namely, the drug was released by molecular diffusion based on the chemical potential gradient. The similar release kinetic for PVP/EC nanofibers loaded with ketoprofen, which is a poorly soluble drug, has also been reported by Yu et al. 28 However, the other nanofibers consisting of EC (at ratios of 10/1/1, 10/2/1 and 10/4/1) also did not exhibit Korsmeyer-Peppas model (Table 3 ). In this case, an increase of EC ratio in the composition of PU mechanism in which the release rate was controlled by the diffusion of drug, when the EC ratios were increased in the nanofiber composition. The results also suggest that the types and ratios of the polymer blends need to be judiciously adjusted so as to optimise the release rate of the drug. Overall, this ability of PU/EC (10/8) electrospun nanofibers has suggested the potential use of it as a drug carrier from which a water-soluble drug release may be in a sustained release fashion.
